Tracking

GLP-1 Weight Loss Plateau: What to Track to Figure It Out

GLP-1 Companion · 7 min read

A plateau on a GLP-1 is one of the most common reasons people lose momentum — and one of the most common reasons clinicians cannot give a confident recommendation. The reason is almost always the same: nobody has the data. A plateau is the period when a tracker matters most, because it is when "what should I change?" becomes an answerable question instead of a guess.

First, Define the Plateau

Not every flat week is a plateau. The clinical definition most clinicians use: no change in weight (within ±1% of body weight) for 4 or more consecutive weeks, in the presence of consistent dose and habits. Plateaus shorter than 4 weeks are noise. Plateaus longer than 8 weeks at a stable dose are worth a clinical conversation.

What to Track During a Plateau

Six categories of data are typically enough to identify the cause. Most plateaus are explained by 1–2 of them, not all six.

1. Dose adherence and timing

• How many of the last 12 doses were taken on schedule?
• Were any doses missed, delayed by more than 24 hours, or taken at a lower-than-prescribed dose?
• When was the last dose escalation, and has enough time passed (typically 4 weeks) to see effect?
• Are you on a starting/sub-therapeutic dose (e.g., 0.25 mg Wegovy, 2.5 mg Mounjaro/Zepbound)? Those doses are not expected to produce sustained loss.

2. Protein and total food intake

Two things commonly happen during a plateau: protein intake quietly drops below maintenance level, or total food intake quietly rises (portion creep). Both are invisible without tracking.

• Average daily protein for the past 2 weeks — target 1.2–2.0 g/kg of body weight.
• A 7-day food log (not permanent — diagnostic only) to surface portion creep.
• Liquid calorie audit: smoothies, lattes, alcohol, juices.
• Eating frequency — has snacking quietly returned as initial appetite suppression normalized?

3. Movement and strength training

• Average daily steps over the last 4 weeks.
• Resistance training sessions per week.
• NEAT (non-exercise activity thermogenesis) signals — has your overall movement dropped since baseline? Many people unconsciously move less as their weight drops.

4. Sleep and stress

• Average hours of sleep per night.
• Subjective sleep quality 1–10.
• Subjective stress level 1–10.
• Any new major stressors — job change, illness, family event.
• Untreated sleep apnea — particularly worth flagging given how strongly it suppresses weight loss.

5. Body composition and measurements

The scale can plateau while body composition continues to improve. This is the single most underappreciated fact about plateaus.

• Waist circumference — has it dropped during the scale plateau? Visceral fat loss often continues when weight stalls.
• Hip, chest, thigh, upper arm — same question.
• Body composition test if available — fat vs. lean mass split.
• Progress photos comparison — month 6 vs. month 3.
• Clothing fit benchmark.

6. Labs and biomarkers (when available)

• HbA1c (if diabetic or pre-diabetic) — improvement here is real progress even on a scale plateau.
• Fasting glucose.
• Lipid panel.
• Blood pressure trend.
• Resting heart rate trend.
• Thyroid function — TSH; underlying hypothyroidism may be present and partially treated.

How to Read a Plateau Log

Once you have 4 weeks of plateau data, work through this decision list. The pattern usually surfaces within minutes.

1. Adherence: Are you actually on the prescribed dose, on schedule? If not — the plateau may be an adherence issue, not a medication issue.
2. Dose level: Are you on a sub-therapeutic dose, waiting on an escalation? Most plateaus at starting doses are not real plateaus.
3. Body composition: Has the scale plateaued while measurements continued to improve? If yes — it is composition change, not failure. Continue.
4. Protein: Below 1.2 g/kg? Likely losing lean mass, which slows metabolic rate. Restore protein.
5. Strength training: Zero sessions per week? Add 2–3. Strongest evidence base for plateau-breaking.
6. Sleep: Below 7 hours? Sleep is one of the most underutilized levers in weight management.
7. Stress: Sustained 8+? Cortisol partially overrides GLP-1 appetite suppression.
8. Portion creep: Has food intake quietly risen as appetite normalized? A short food log will reveal this.
9. None of the above? Now is the time for the conversation with your clinician about dose adjustment.

A plateau worked through with data takes 4–8 weeks to resolve. A plateau worked through with guesses sometimes never resolves — and is the most common reason people stop their medication prematurely.

Common Mistakes During a Plateau

• Stopping the medication. Discontinuing during a plateau almost always leads to regain — the plateau is not a signal to stop.
• Cutting calories drastically. Triggers stronger metabolic adaptation and accelerates muscle loss.
• Adding cardio without resistance training. Does not preserve lean mass and appetite often compensates for calories burned.
• Stopping tracking. The plateau is when tracking is most useful — quitting the log removes the signal you need.
• Comparing to other people. Your dose, age, starting weight, and history are unique. Plateau patterns differ.

What to Bring to the Plateau Doctor Visit

A one-page summary built from the categories above is the highest-value artifact you can bring to a follow-up about a plateau.

1. Plateau definition: weight range and duration.
2. Adherence: doses taken vs. scheduled.
3. Current dose and last escalation date.
4. Body measurement and composition changes during the plateau.
5. Daily averages: protein, steps, sleep, training sessions.
6. Any new stressors or life changes.
7. Lab values if drawn.
8. Your top question — "should we escalate?" / "should we change lifestyle first?" / "is this medication still right?"

Key Takeaways

• A plateau is ≥4 weeks of stable weight at a stable dose with consistent habits.
• Track six categories: adherence, food/protein, movement, sleep/stress, measurements, labs.
• Most plateaus are explained by 1–2 categories — the data tells you which.
• Scale plateaus while measurements continue to improve are body-composition change, not failure.
• Bring a structured plateau summary to your clinician — it produces faster, better decisions than retrospective memory.

Sources

• Wilding et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM.
• Jastreboff et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. NEJM.